<DOC>
	<DOCNO>NCT00169624</DOCNO>
	<brief_summary>Peripheral coronary endothelial dysfunction type 2 diabetic patient may influence therapeutic . Using Radial flow monitor myocardial perfusion magnetic resonance imaging , design control randomize double blind study test hypothesis endothelial dysfunction reverse follow 3 month Metformin administration v gliclazide . 30 patient include .</brief_summary>
	<brief_title>Peripheral Coronary Endothelial Dysfunction In Type 2diabetic Patients- Role Metformin</brief_title>
	<detailed_description />
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Gliclazide</mesh_term>
	<criteria>1870 year old , type 2 diabetes , non significant coronary atherosclerosis inclusion coronary angiogram ( ie coronary stenosis &gt; 70 % ) , HbA1c &lt; 9 % significant coronary stenosis ( &gt; 70 % ) , lack informed consent , unstable hypertension , renal failure , contraindication metformin gliclazide , pregnancy , atrial fibrillation , contraindication MRI , adenosine , brachial artery calcification</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>Diabetes ,</keyword>
	<keyword>coronary endothelial dysfunction ,</keyword>
	<keyword>metformin ,</keyword>
	<keyword>glyclazide ,</keyword>
	<keyword>MRI .</keyword>
</DOC>